MAPT and Alzheimer disease: To further validate the existence of gauche p-tau and distinguish it from other p-tau conformers, we immunodepleted gauche p-tau from Alzheimer’s disease (AD) brain extracts and assessed the remaining tau population using a pan-tau antibody (Tau-5).